Kinurenin és metabolitjai idegrendszeri betegségekben.

Translated title of the contribution: Kynurenine and its metabolites in nervous system diseases

L. Vécsei, F. Schwab

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Kynurenine is a metabolite of the tryptophan-nicotine-amide-adenine-dinucleotide pathway. Recent preclinical and clinical data suggest that kynurenine and its metabolites (kynurenic acid, quinolinic acid) may play important role in the pathogenesis of neurological and other disorders (Huntington's disease, epilepsy, hypoxia, ulcus, hepatic and infectious diseases). Experimental data and theoretical considerations suggest that modification of kynurenine metabolism and influence of the concentrations of kynurenine metabolites may be useful therapeutic strategies in treatment of several disorders. This review is a summary of the pathobiochemical mechanisms and possible therapeutic strategies.

Original languageHungarian
Pages (from-to)1803-1807
Number of pages5
JournalOrvosi Hetilap
Volume133
Issue number29
Publication statusPublished - Jul 19 1992

Fingerprint

Kynurenine
Nervous System Diseases
Kynurenic Acid
Quinolinic Acid
Huntington Disease
Adenine
Nicotine
Amides
Tryptophan
Ulcer
Communicable Diseases
Epilepsy
Liver
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kinurenin és metabolitjai idegrendszeri betegségekben. / Vécsei, L.; Schwab, F.

In: Orvosi Hetilap, Vol. 133, No. 29, 19.07.1992, p. 1803-1807.

Research output: Contribution to journalArticle

Vécsei, L & Schwab, F 1992, 'Kinurenin és metabolitjai idegrendszeri betegségekben.', Orvosi Hetilap, vol. 133, no. 29, pp. 1803-1807.
Vécsei, L. ; Schwab, F. / Kinurenin és metabolitjai idegrendszeri betegségekben. In: Orvosi Hetilap. 1992 ; Vol. 133, No. 29. pp. 1803-1807.
@article{a285c32ded8a45d899bfafc55b619899,
title = "Kinurenin {\'e}s metabolitjai idegrendszeri betegs{\'e}gekben.",
abstract = "Kynurenine is a metabolite of the tryptophan-nicotine-amide-adenine-dinucleotide pathway. Recent preclinical and clinical data suggest that kynurenine and its metabolites (kynurenic acid, quinolinic acid) may play important role in the pathogenesis of neurological and other disorders (Huntington's disease, epilepsy, hypoxia, ulcus, hepatic and infectious diseases). Experimental data and theoretical considerations suggest that modification of kynurenine metabolism and influence of the concentrations of kynurenine metabolites may be useful therapeutic strategies in treatment of several disorders. This review is a summary of the pathobiochemical mechanisms and possible therapeutic strategies.",
author = "L. V{\'e}csei and F. Schwab",
year = "1992",
month = "7",
day = "19",
language = "Hungarian",
volume = "133",
pages = "1803--1807",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "29",

}

TY - JOUR

T1 - Kinurenin és metabolitjai idegrendszeri betegségekben.

AU - Vécsei, L.

AU - Schwab, F.

PY - 1992/7/19

Y1 - 1992/7/19

N2 - Kynurenine is a metabolite of the tryptophan-nicotine-amide-adenine-dinucleotide pathway. Recent preclinical and clinical data suggest that kynurenine and its metabolites (kynurenic acid, quinolinic acid) may play important role in the pathogenesis of neurological and other disorders (Huntington's disease, epilepsy, hypoxia, ulcus, hepatic and infectious diseases). Experimental data and theoretical considerations suggest that modification of kynurenine metabolism and influence of the concentrations of kynurenine metabolites may be useful therapeutic strategies in treatment of several disorders. This review is a summary of the pathobiochemical mechanisms and possible therapeutic strategies.

AB - Kynurenine is a metabolite of the tryptophan-nicotine-amide-adenine-dinucleotide pathway. Recent preclinical and clinical data suggest that kynurenine and its metabolites (kynurenic acid, quinolinic acid) may play important role in the pathogenesis of neurological and other disorders (Huntington's disease, epilepsy, hypoxia, ulcus, hepatic and infectious diseases). Experimental data and theoretical considerations suggest that modification of kynurenine metabolism and influence of the concentrations of kynurenine metabolites may be useful therapeutic strategies in treatment of several disorders. This review is a summary of the pathobiochemical mechanisms and possible therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=0027123158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027123158&partnerID=8YFLogxK

M3 - Article

C2 - 1386152

AN - SCOPUS:0027123158

VL - 133

SP - 1803

EP - 1807

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 29

ER -